Back to Search
Start Over
Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.
- Source :
-
Toxins [Toxins (Basel)] 2021 Feb 18; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 18. - Publication Year :
- 2021
-
Abstract
- Unilateral peripheral facial nerve palsy jeopardizes quality of life, rendering psychological consequences such as low self-esteem, social isolation, anxiety, and depression. Among therapeutical approaches, use of Botulinum toxin type A (BoNT-A) on the nonparalyzed side has shown promising results and improvement of quality of life. Nevertheless, the correct technique is paramount, since over-injection of the muscles can result in lack of function, leading to a "paralyzed" appearance, and even worse, functional incompetence, which may cause greater distress to patients. Therefore, the objective of this article is to provide a practical guideline for botulinum toxin use in facial palsy. To this aim, adequate patient assessment, BoNT-A choice, injection plan and dosage, and injection techniques are covered.
- Subjects :
- Acetylcholine Release Inhibitors adverse effects
Adult
Bell Palsy diagnosis
Bell Palsy physiopathology
Botulinum Toxins, Type A adverse effects
Facial Muscles physiopathology
Facial Paralysis diagnosis
Facial Paralysis physiopathology
Female
Humans
Injections, Intramuscular
Quality of Life
Treatment Outcome
Acetylcholine Release Inhibitors administration & dosage
Bell Palsy drug therapy
Botulinum Toxins, Type A administration & dosage
Facial Muscles drug effects
Facial Paralysis drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2072-6651
- Volume :
- 13
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Toxins
- Publication Type :
- Academic Journal
- Accession number :
- 33670477
- Full Text :
- https://doi.org/10.3390/toxins13020159